BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8127625)

  • 1. Screen-detected breast carcinomas--do they differ from those diagnosed outside screening programs?
    Toikkanen S; Dean PB; Joensuu H
    Pathol Annu; 1994; 29 Pt 1():261-79. PubMed ID: 8127625
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening mammography may not be effective at any age.
    Wilkerson BF; Schooff M
    J Fam Pract; 2000 Apr; 49(4):302, 371. PubMed ID: 10778833
    [No Abstract]   [Full Text] [Related]  

  • 3. The debate on breast cancer screening with mammography is important.
    Gøtzsche PC
    J Am Coll Radiol; 2004 Jan; 1(1):8-14. PubMed ID: 17411511
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Paci E; Ponti A; Crocetti E; Zappa M; Segnan N
    J Natl Cancer Inst; 2005 Dec; 97(24):1853-4; author reply 1854. PubMed ID: 16368949
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognosis and pathology of screen-detected carcinomas: how different are they?
    Nagtegaal ID; Allgood PC; Duffy SW; Kearins O; Sullivan EO; Tappenden N; Wallis M; Lawrence G
    Cancer; 2011 Apr; 117(7):1360-8. PubMed ID: 21425135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for breast cancer.
    Duffy SW; Smith RA; Gabe R; Tabár L; Yen AM; Chen TH
    Surg Oncol Clin N Am; 2005 Oct; 14(4):671-97. PubMed ID: 16226686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mass screening of cancer of the breast: politico-economic objectives and their underestimated risks].
    Dilhuydy MH
    Contracept Fertil Sex; 1998 Jun; 26(6):420-4. PubMed ID: 9691519
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reduced mortality with mammographic screening. The natural course, too rough methods resulted in miscalculation on breast cancer].
    Rutqvist LE
    Lakartidningen; 1999 Mar; 96(10):1210-1. PubMed ID: 10193130
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathological and biological nature of screen-detected breast carcinomas: a morphological and immunohistochemical study.
    Cowan WK; Kelly P; Sawan A; Cunliffe WJ; Henry L; Higgs MJ; Lunt LG; Young JR; Horne CH; Angus B
    J Pathol; 1997 May; 182(1):29-35. PubMed ID: 9227339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening: success amid conflict.
    Leitch AM
    Surg Oncol Clin N Am; 1999 Oct; 8(4):657-72, vi. PubMed ID: 10452933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of screen-detected breast cancers: results of a population based study.
    Cortesi L; Chiuri VE; Ruscelli S; Bellelli V; Negri R; Rashid I; Cirilli C; Fracca A; Gallo E; Federico M
    BMC Cancer; 2006 Jan; 6():17. PubMed ID: 16430776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mammography screening controversy.
    Kopans DB
    Cancer J Sci Am; 1998; 4(1):22-4. PubMed ID: 9467041
    [No Abstract]   [Full Text] [Related]  

  • 13. Infiltrating lobular carcinoma of the breast detected by screening.
    Schroën AM; Wobbes T; van der Sluis RF
    Br J Surg; 1998 Mar; 85(3):390-2. PubMed ID: 9529500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected.
    Kafadar K; Prorok PC
    Stat Med; 2009 Jul; 28(16):2116-46. PubMed ID: 19424959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer.
    Tuma RS
    J Natl Cancer Inst; 2006 Jan; 98(2):86-7. PubMed ID: 16418506
    [No Abstract]   [Full Text] [Related]  

  • 16. Mammographic screening: does it work?
    Handler S
    Minn Med; 2003 Dec; 86(12):6-7. PubMed ID: 14719608
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening mammography in women 40 to 49 years of age.
    Lisby MD
    Am Fam Physician; 2004 Nov; 70(9):1750-2. PubMed ID: 15554494
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
    Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will screening for breast cancer reduce mortality? Evidence from the first year of screening in Avon.
    Nicholson S; Webb AJ; Coghlan B; Farndon JR; Armstrong JS; Davies JD
    Ann R Coll Surg Engl; 1993 Jan; 75(1):8-11; discussion 12. PubMed ID: 8422159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic screening reduces risk of breast carcinoma recurrence.
    Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
    Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.